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Introduction
The steroid hormones influence the growth, differ entiation, and funct ioning of many tar get tissues. Estr ogens also play an import ant r ole in bone maintenance, in centr al ner vous syst em and in car diovascular syst em wher e est r ogens have cert ain car diopr ot ect ive effect s [5, 7, 20] . Est rogen recept or s (ERs) belong t o t he nuclear recept or super family, and are ligand-inducible t r anscription fact ors t hat mediat e the biological effect s of est rogens and ant i-est r ogens. Two ER subt ypes, encoded by differ ent genes have been isolat ed in mammals, ER and ER [6, 9, 19] . Reverse t ranscr ipt ionpolymer ase chain r eact ion (RT-PCR) analysis indicat ed that ER is highly expr essed in pr ostate and ovar y [9, 16] , but moder at e expression was det ect ed in ot her t issues including test is and ut erus, some of which also seem to express ER [10] . In t he pr esence of est rogen or estr ogen-like ligands, a confor mat ional change in t he ER is induced, an event t hat promotes ER homodimerization and high-affinit y binding of ER to specific sit es on DNA. Once bound t o DNA, the estrogen-responsive genes, results in tissue-specific est rogenic responses.
Human diet cont ains sever al plant -der ived, nonst er oidal weakly est rogenic compounds [8] . Chemically, t he phytoestrogens may be divided into three main classes; flavonoids (genist ein, naringenin, and kaempfer ol); coumest ans (coumestr ol); and lignans (ent er odiol and ent erolact one) [11] . Phyt oest r ogens act as weak mit ogens for br east t umor cells in vitro, compet e wit h 17 -est r adiol for binding ER pr ot ein, and induce act ivit y of estr ogen-responsive r eport er gene constr uct s in t he pr esence of ER pr otein [12, 13, 15] . It may also act as chemopreventive agents by t he fact t hat int ake of phyt oest r ogens is significantly higher in countr ies wher e the incidence of br east and prost at e cancer s is low [14] .
Pueraria m irifica (PM) is an indigenous her b of Thailand, known as "Kwao Kr eu" or "Kwao Kr eu Kao" (White Kwao Kr eu). Similar t o soybean, it belongs t o t he same subfamily and possesses sever al compounds t hat act as phytoestr ogens like phenol mir oest r ol and deoxymiroestr ol [3] . For over a cent ur y, the tuberous r oot of PM has been used by local Thai people for rejuvenat ing and enhancing endur ance and vigor. Chansakaow et al. [4] repor t ed t hat nine isoflavonoids including a new pt er ocar pene, puemir icar pe were isolated fr om t he tuber ous root of PM and showed estr ogenic act ivit y in MCF-7 human br east cancer cells. In the present study, estrogenic activity of PM was evaluat ed in recombinant yeast assay expr essing human est rogen r ecept or (hER) and cor r esponding -galact osidase r epor ter gene, in MCF-7 human breast cancer cells proliferation assay, and in t ransient t r ansfect ion assay using HepG2 human hepatoma cells. Estrogenic response is created by cotransfection with recombinant rat ER cDNA in the presence of an estr ogen-dependent luciferase r epor t er plasmid (C3-luc).
Requirement of Metabolic

Materials and Methods
Chem icals
17 -Est r adiol (E2) and 4-hydroxyt amoxifen (OHT) wer e purchased fr om Sigma Chemical Co. (St. Louis, MO, USA). Pueraria m irifica (PM) as test material was obt ained from Cheil J edang (In-chon, Kor ea). All t est mat er ials wer e dissolved wit h appropr iat e solvents for each experiment. 
2-2. Estr ogenicit y assay in yeast
The yeast cells wer e dilut ed t o an OD600nm value of 0.03 in select ive medium plus 50 M CuSO4 t o induce r ecept or pr oduction. The dilut ed yeasts were aliquoted into 50-ml conical t ube (5 ml/tube) and 5 of 0.025, 0.25, 2.5, 25, 250, 2.5 103 and 2.5 104 ng/ml concet r at ions of PM and E2 (positive cont rol) in absolut e ethanol (0.1%) wer e added. The cult ur es were incubat ed for 18 h in a shaking incubat or at 30 wit h 300 r pm. Aft er incubation the yeast culture samples wer e dilut ed with appropr iat e select ive medium t o an OD600nm value of 0.25 and 100 was added t o each well of a 96-well microt iter plat e. Each sample was assayed in quadruplicat e. -Galact osidase act ivit y was induced by t he addition of 100 of a Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl and 1 mM MgSO4, pH 7.0) cont aining 2 mg/ml 0-nit r ophenyl--D-galact opyr anoside (ONPG), 0.1% sodium dodecyl sulfate (SDS), 50 mM -mercaptoet hanol, and 200 U/ml oxalyticase (Enzogenetics, Cor navillis, OR, USA). The OD420nm and OD590nm values of each well were measured using Titer tek Multiscan MCC/344 plate r eader aft er allowing t he tube t o stand for 20 min. The OD420nm value of each well was corr ect ed by subt r act ing the OD590nm value.
3. MCF-7 cell proliferation assay MCF-7 cells wer e gr own in phenol r ed-fr ee D-media (EMEM cont aining 50% increase of all essent ial amino acids except glut amine, 50% incr ease of all vit amins, and 100% increase of all non-essent ial amino acids) supplemented wit h 5% fetal bovine serum (FBS) and 3ml/L of PSN antibiot ic mixt ur e (Gibco, NY, USA). The cells were placed in an incubat or maint ained at 5% CO2, 95% air and 100% humidit y at 37 . PM was then diluted wit h t he phenol red-fr ee D-media supplement ed wit h 5% dext ran-coated char coal-str ipped FBS (DCC-FBS; Hyclone, UT, USA) and 3ml/L PSN antibiotic mixture (test media). The concentr ating DMSO in the vehicle cont rol media was 0.1%. E2 was used as posit ive cont r ol and OHT was co-tr eat ed wit h E2.
The cells (5 104/ml) wer e plat ed in 6-well cult ur e plate (2ml/well) in t riplicate, and allowed t o at t ach for 24 h. The phenol red-fr ee D-media was r eplaced with phenol r ed-free D-media supplemented wit h 5% DCC-FBS, followed by incubat ion for 24h, t hen the medium was r emoved and replaced by t est medium (pr epared as above) containing var ious concent rations of PM. The cells were incubat ed for 3 days at 37 , and the t est media wer e changed once. The cells were t hen washed t hr ee t imes wit h phosphat e-buffer ed saline (PBS) and lysed wit h 1ml of 0.1N NaOH. The lysat es were t r ansfer r ed int o a 1.5-ml microcentr ifuge t ube and cent r ifuged for 2 minut es. The OD260nm value of t he clear lysat e was measured wit h a spect r ophot omet er (Du 650, Beckman, Fuller t on, USA).
Transie nt transfection assay in He pG2 cell
4-1. Plating and t ransfection HepG2 human hepatoma cells (Kor ean Cell Line Bank, Korea) wer e plated in tr iplicat e in 24-well plat e at a density of 5 104 cells/well in complete medium consist ing of phenol red-fr ee Eagle' s minimal essent ial medium (GIBCO/BRL, Gr and Island, NY, USA) supplemented wit h 10 % DCC-FBS, 2% L-glut amine, and 0.1 % sodium pyr uvate. Cells were incubat ed for 24 h at 37 in a humidified at mospher e of 5 % CO2 air and t hen tr ansfect ed following t he Superfect procedure (Qiagen, Valencia, CA, USA) wit h t wo plasmids: (1) 0.4 g/ml r ecept or plasmid encoding r at ER , (2) 0.8 g/well C3-luc, repor t er plasmid. Transfect ed cells wer e t hen rinsed wit h PBS and t r eated wit h var ious concent r at ions of PM or wit h absolut e alcohol (vehicle contr ol) in complet e medium. Aft er 24 h incubat ion, t reat ed cells wer e r insed wit h PBS and lysed wit h 65 of passive lysis buffer (Promega, Madison, WI, USA). Lysat e was plat ed int o 96-well plates for luciferase det er minat ion.
4-2. Dual Luciferase r epor ter assay A 100
volume of Lucifease assay reagent II (Pr omega) was added int o each well cont aining 20 of lysate and then fir efly lucifer ase act ivity was deter mined immediately using microplate luminometer LB96P (Berthold t echnologies, Germany). After deter minat ion of firefly lucifer ase act ivity, 100 of St op & Glo reagent (Pr omega) was added and Renilla lucifer ase act ivity was det er mined. Using t he DLRTM Assay Syst em (Pr omega), t he luminescence fr om t he firefly luciferase reaction is ' experimental'reporter and the luminescent r eact ion of Renilla lucifer ase is ' contr ol' r epor ter .
Results
R ecom binant yeast assay
A t wo-plasmid syst em consist ing of human Estr ogen r ecept or (hER) expression plasmid and a repor t er plasmid containing est rogen r esponse element (ERE) was employed t o st udy est r ogenic pr opert y of PM (Fig. 1) . The r eport er gene -galact osidase gave a measur e for ligand-dependent t ransactivation. In recombinant yeast assay, 0.025, 0.25, 2.5, 25, 2.5 102, 2.5 103, 2.5 104 ng/ml concent rations of PM did not induce any est r ogenic act ivities while 10-9 of E2 as posit ive contr ol had st rong est rogenic act ivit y compared wit h cont rol (p>0.05). Fig. 1 . Effect of Pueraria m irifica on t he yeast expressing human estr ogen recept or . C, unt reat ed; V, vehicle (1% Et OH); E2, 10-9 M 17 -est radiol; PM1, 0.025 ng/ml; PM2, 0.25 ng/ml; PM3, 2.5 ng/ml; PM4, 25 ng/ml; PM5, 2.5 102 ng/ml, PM6, 2.5 103 ng/ml; PM7, 2.5 104 ng/ml. , significant ly differ ent from contr ol (p>0.05)
MCF-7 cell proliferation assay
Est r ogenic activit y of PM was est imat ed in t er ms of it s proliferation-promoting effects in MCF-7 human breast cancer cells (Fig. 2) . Estr ogenic activit y was obser ved significant ly (p>0.05) compared wit h contr ol fr om 2.5 ng/ml concentr ation of PM in a dose-dependent manner . The PM concent rat ion of maximal estrogen activity was 2.5 103 ng/ml and exhibit ed st r ong pr olifer at ion similar to E2 at t he concent r at ion of 2.5 1010 M. DNA content s also decr eased to as low as t he level of vehicle cont rol when OHT, est r ogen recept or ant agonist , was co-tr eat ed wit h PM in a dose of 2.5 103 ng/ml, maximal effect ive concent r at ion of PM or 2.5 1010 M of E2, r espect ively.
H epG2 cell transient transfe ction assay
Est r ogenic act ivit y of PM was char act er ized in HepG2 human hepatoma cells transfected with rER plus an est r ogenresponsive luciferase r epor ter gene (Fig. 3) . The est r ogenic activit y of PM in HepG2 cell was similar to t hat of PM in MCF-7 cells. PM was complet e agonists at t he ER and 2.5 103 ng/ml of PM, maximal effect ive concent r at ion and showed st r onger estr ogenic act ivity t han E2 at t he concent ration of 10-8 M. Fig. 2 . Effect of Pueraria m irifica on the prolifer at ion of MCF-7 human br east cancer cells. C, unt r eated; V, vehicle (1% Et OH); E2, 2.5 10-10 M 17 -est r adiol; PM3, 2.5 ng/ml; PM4, 25 ng/ml; PM5, 2.5 102 ng/ml, PM6, 2.5103 ng/ml; PM7, 2.5 104 ng/ml; OHT, 10-6 M 4-hydr oxyt amoxifen. , significantly different fr om cont r ol (p>0.05) Fig. 3 . Effect of Pueraria m irifica on t he HepG2 human hepat oma cells. C, E2, 1.0 10-8 M 17 -est r adiol; PM1, 0.025 ng/ml; PM2, 0.25 ng/ml; PM3, 2.5 ng/ml; PM4, 25 ng/ml; PM5, 2.5 102 ng/ml, PM6, 2.5 103 ng/ml; PM7, 2.5 104 ng/ml. , significant ly differ ent from cont rol (p>0.05)
Discussion
A wide range of chemicals der ived fr om plant and human-made xenobiot ics ar e report ed t o have hor monal activit y and nowadays t her e ar e incr easing tendencies to get hormonal recipes using some natural products phyt oest rogens. Pueraria m irifica (PM) is commonly known in Thai as Whit e Kwao Krua, t hat has been used as a r ejuvenating folk medicine. The enlarged under ground t uber accumulat es phyt oest r ogens compr ising isoflavones such as daidzin, daidzein, genist in, genist ein and puerar in. Recent st udies have evaluated estrogenic activity of the isolated phyt oest rogens from Pueraria m irifica (PM) such as kwakhur in, mir oest r ol, and deoxymiroestr ol in MCF-7 human beast cancer cells [4] .
In t his st udy, three in vitro assay syst ems wer e used t o evaluate the est rogenic act ivit y of PM, and present results showed t hat PM did not induce estr ogenic effects in r ecombinant yeast assay syst em, which PM in it self did not bind estr ogen r eceptor . However , PM pr omot ed MCF-7 cell pr olifer ation in a dose-dependent manner and co-t reat ment PM wit h 4-hydr oxyt amoxifen inhibit ed PM-induced cell pr olifer ation. Chansakaow et al. [4] suppor t ed our result on t he estr ogenic act ivity of PM in MCF-7 human br east cancer cell. This indicat es t hat PM may be metabolized t o a for m capable of binding t o t he estr ogen recept or in MCF-7 cells, wher eas the yeast syst em may not have the capabilit y to metabolically activate PM by the lack of mammalian met abolic enzymes using HepG2 human hepat oma cell would be able t o know whet her PM is metabolized befor e induction of estr ogenic act ivit y. The evaluation of PM in HepG2 cell lines confir med t hat PM may be met abolized t o induced estr ogenic act ivit y.
The r ecombinant yeast system can accur at ely predict t he estrogenic activity of various phytoestrogens in the mammalian cell syst em, and it is useful for test ing and det ect ing of novel est r ogenic subst ances in t he envir onment and nat ur al specimens [1] . Also, ther e are many advant ages of yeast syst em t o st udy est r ogen r eceptor function such as ease of manipulat ion, r apid att ainment of stable t r ansfor mant s, and abilit y t o pr ocess lar ge sam ple number s quickly and inexpensively. However , t he yeast assay syst em cannot complet ely addr ess met abolism of t he compound. Some r esult s relevant t o t he met abolic compet ence of r ecombinant yeast assay have been reported previously [17] . For example, Methoxychlor is met abolically conver t ed t o the active estr ogenic pr oduct HPTE [2] . Shelby et al. [18] showed t hat methoxychlor (proestr ogen) was inact ive in the yeast assay syst em, whereas HPTE was act ive. This suggests t hat yeast assay syst em lack t he abilit y t o demet hylate met hoxychlor and may miss cer t ain pr oest rogens, leading to negat ive r esult s. HepG2 cell based syst em is appar ent ly less sensitive t o t he action of 17 -est radiol compar ed to t he yeast syst em but t his syst em has t he known pr oper ties of hepatocytes to metabolize estrogens [1] . Based on the r esult s t hat PM did not induce est r ogenic activit y in r ecombinant yeast cells, but induced est r ogenic act ivity in MCF-7 human br east cancer cells and HepG2 human hepat oma cells, t herefor e, PM in itself may neit her bind est rogen recept or nor show estr ogenic effect , but may r equir e metabolic act ivat ion for est r ogenic act ivit y t hat may not be obser ved properly by yeast system.
